NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting
Clinical Trials
28 trialsNCT06056635 2024-09-25
A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures
Boston Children's Hospital
Phase NA Recruiting
NCT02913612 2024-03-12
TIM01
Duke University
Phase 2 Completed
NCT04336163 2024-01-30
Skin Imaging to Inform Laser Treatments
University of California, Irvine
Phase NA Terminated
NCT01873131 2023-11-02
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
Massachusetts General Hospital
Phase NA Recruiting
NCT04020419 2023-10-23
Pediaberry
Indiana University
Phase EARLY_PHASE1 Terminated
NCT01685398 2023-09-21
Topical Timolol for Superficial Infantile Hemangioma
Mahidol University
Phase 3 Completed
NCT05327309 2023-09-13
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
Shaheed Zulfiqar Ali Bhutto Medical University
Phase NA Completed
NCT04077515 2023-01-30
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Phase 4 Completed
NCT02342275 2022-06-16
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
West China Hospital
Phase 3 Completed
NCT04836884 2022-04-21
Vascular Anomaly Pathology and Genomics Biopsy Study
Mayo Clinic
Phase NA Completed
NCT04684667 2020-12-24
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
Assiut University
Phase 2 Unknown
NCT02505971 2020-10-28
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
The Hospital for Sick Children
Phase 3 Completed
NCT04065217 2019-08-22
NTDL980
University of Baghdad
Phase NA Completed
NCT01908972 2018-12-19
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
Seoul National University Hospital
Phase 4 Completed
NCT02731287 2018-11-14
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 2 Completed
NCT01074437 2018-10-04
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Phase 2 Terminated
NCT01147601 2017-07-05
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Oregon Health and Science University
Phase EARLY_PHASE1 Terminated
NCT02496013 2017-04-07
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
Peking Union Medical College Hospital
Phase 1 Unknown
NCT02145884 2017-02-13
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
Rady Children's Hospital, San Diego
Phase 2 Completed
NCT01743885 2016-06-01
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
University Hospital, Montpellier
Phase 3 Terminated
NCT00967226 2016-02-24
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Children's National Research Institute
Phase 2 Terminated
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed
NCT01408056 2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT00394888 2013-09-20
Hemangioma Associated With High Rates of Morbidity
Medical College of Wisconsin
Phase NA Completed
NCT00555464 2013-06-11
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
Medical College of Wisconsin
Phase 2 Terminated
NCT00374335 2011-09-16
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
Children's Mercy Hospital Kansas City
Phase NA Completed
NCT00601016 2008-01-25
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
St. Justine's Hospital
Phase 2 Completed